Living well with Heart Failure report 2022
DAPAGLIFLOZIN ACCEPTED FOR USE WITHIN NHS SCOTLAND
Legal right to 2 week review of patients with suspected heart failure (HF)
NICE Impact Report Cardiovascular Disease Management
NICE Recommends Dapagliflozin for Heart Failure
NICE in the UK recommends Dapagliflozin (FORXIGA) to treat heart failure with reduced ejection fraction for patients with or without Diabetes.